174 related articles for article (PubMed ID: 25026214)
1. The elusive rat model of conditioned placebo analgesia.
McNabb CT; White MM; Harris AL; Fuchs PN
Pain; 2014 Oct; 155(10):2022-32. PubMed ID: 25026214
[TBL] [Abstract][Full Text] [Related]
2. A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain.
Smith LJ; Krugner-Higby L; Clark M; Wendland A; Heath TD
Comp Med; 2003 Jun; 53(3):280-7. PubMed ID: 12868573
[TBL] [Abstract][Full Text] [Related]
3. Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems.
Guo JY; Wang JY; Luo F
J Psychopharmacol; 2010 Oct; 24(10):1561-7. PubMed ID: 19395430
[TBL] [Abstract][Full Text] [Related]
4. Escalating morphine dosage fails to elicit conditioned analgesia in a preclinical chronic neuropathic pain model.
Boorman DC; Keay KA
Behav Pharmacol; 2021 Sep; 32(6):479-486. PubMed ID: 34320522
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of morphine antiallodynic efficacy by ACPT-III, a group III metabotropic glutamate receptor agonist, in rat spinal nerve ligation-induced neuropathic pain.
Lee HG; Park SK; Yoon MH
Pharmacol Biochem Behav; 2010 Jul; 96(1):108-13. PubMed ID: 20434481
[TBL] [Abstract][Full Text] [Related]
6. Placebo-induced analgesia in an operant pain model in rats.
Nolan TA; Price DD; Caudle RM; Murphy NP; Neubert JK
Pain; 2012 Oct; 153(10):2009-2016. PubMed ID: 22871471
[TBL] [Abstract][Full Text] [Related]
7. Changes in morphine reward in a model of neuropathic pain.
Cahill CM; Xue L; Grenier P; Magnussen C; Lecour S; Olmstead MC
Behav Pharmacol; 2013 Jun; 24(3):207-13. PubMed ID: 23591124
[TBL] [Abstract][Full Text] [Related]
8. Failure of Placebo Analgesia Model in Rats with Inflammatory Pain.
Yin XS; Yang JY; Cao S; Wang Y
Neurosci Bull; 2020 Feb; 36(2):121-133. PubMed ID: 31435837
[TBL] [Abstract][Full Text] [Related]
9. The importance of genetic background on pain behaviours and pharmacological sensitivity in the rat spared serve injury model of peripheral neuropathic pain.
Rode F; Thomsen M; Broløs T; Jensen DG; Blackburn-Munro G; Bjerrum OJ
Eur J Pharmacol; 2007 Jun; 564(1-3):103-11. PubMed ID: 17383631
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of amitriptyline differentially alters neuropathic pain-related behaviour in the presence and absence of a depressive-like phenotype.
Burke NN; Finn DP; Roche M
Behav Brain Res; 2015 Feb; 278():193-201. PubMed ID: 25300472
[TBL] [Abstract][Full Text] [Related]
11. Morphine, gabapentin, or their combination for neuropathic pain.
Gilron I; Bailey JM; Tu D; Holden RR; Weaver DF; Houlden RL
N Engl J Med; 2005 Mar; 352(13):1324-34. PubMed ID: 15800228
[TBL] [Abstract][Full Text] [Related]
12. Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain.
Schröder W; Vry JD; Tzschentke TM; Jahnel U; Christoph T
Eur J Pain; 2010 Sep; 14(8):814-21. PubMed ID: 20541444
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model.
Miyazaki R; Yamamoto T
Anesth Analg; 2012 Jul; 115(1):182-8. PubMed ID: 22415534
[TBL] [Abstract][Full Text] [Related]
14. Olfactory cues and morphine-induced conditioned analgesia in rats.
Valone JM; Randall CK; Kraemer PJ; Bardo MT
Pharmacol Biochem Behav; 1998 May; 60(1):115-8. PubMed ID: 9610932
[TBL] [Abstract][Full Text] [Related]
15. Ethosuximide reduces allodynia and hyperalgesia and potentiates morphine effects in the chronic constriction injury model of neuropathic pain.
Hamidi GA; Ramezani MH; Arani MN; Talaei SA; Mesdaghinia A; Banafshe HR
Eur J Pharmacol; 2012 Jan; 674(2-3):260-4. PubMed ID: 22134003
[TBL] [Abstract][Full Text] [Related]
16. Combination of tramadol with minocycline exerted synergistic effects on a rat model of nerve injury-induced neuropathic pain.
Mei XP; Chen L; Wang W; Wu D; Wang LY; Zhang T; Zhang H; Xu LX; Li YQ
Neurosignals; 2013; 21(3-4):184-96. PubMed ID: 22964800
[TBL] [Abstract][Full Text] [Related]
17. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems.
Amanzio M; Benedetti F
J Neurosci; 1999 Jan; 19(1):484-94. PubMed ID: 9870976
[TBL] [Abstract][Full Text] [Related]
18. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
Hua S; Cabot PJ
Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
[TBL] [Abstract][Full Text] [Related]
19. Optimization and pharmacological characterization of a refined cisplatin-induced rat model of peripheral neuropathic pain.
Han FY; Wyse BD; Smith MT
Behav Pharmacol; 2014 Dec; 25(8):732-40. PubMed ID: 25325291
[TBL] [Abstract][Full Text] [Related]
20. The analgesic efficacy and safety of intra-articular morphine and mepivicaine following temporomandibular joint arthroplasty.
Zuniga JR; Ibanez C; Kozacko M
J Oral Maxillofac Surg; 2007 Aug; 65(8):1477-85. PubMed ID: 17656271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
